These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16648494)

  • 1. ASCO in the 21st century: challenges and opportunities--ASCO presidential address 2005.
    Johnson DH
    J Clin Oncol; 2006 May; 24(13):1967-71. PubMed ID: 16648494
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisions of and clarifications to the ASCO conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jan; 24(3):517-8. PubMed ID: 16365172
    [No Abstract]   [Full Text] [Related]  

  • 3. American Society of Clinical Oncology: background for update of conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2387-93. PubMed ID: 12721280
    [No Abstract]   [Full Text] [Related]  

  • 4. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology: revised conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2394-6. PubMed ID: 12721282
    [No Abstract]   [Full Text] [Related]  

  • 6. ASCO 2011: broadening the horizons of cancer research.
    Crane K
    J Natl Cancer Inst; 2011 Jul; 103(13):999-1001. PubMed ID: 21693729
    [No Abstract]   [Full Text] [Related]  

  • 7. What ASCO does for its members.
    Hammond DB
    J Clin Oncol; 2004 Jun; 22(11):2251-2. PubMed ID: 15169817
    [No Abstract]   [Full Text] [Related]  

  • 8. ASCO Rx for high drug costs: doctors and patients need to talk.
    Nicholas J
    J Natl Cancer Inst; 2009 Nov; 101(21):1441-4. PubMed ID: 19828870
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethics in oncology: consulting for the investment industry.
    Berlin J; Bruinooge SS; Tannock IF
    J Clin Oncol; 2007 Feb; 25(4):444-6. PubMed ID: 17264341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Task force 4: Appropriate clinical care and issues of "self-referral".
    Ritchie JL; Wolk MJ; Hirshfeld JW; Messer JV; Peterson ED; Prystowsky EN; Gardner TJ; Kimball HR; Popp RL; Smaha L; Smith SC; Wann LS
    J Am Coll Cardiol; 2004 Oct; 44(8):1740-6. PubMed ID: 15489118
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges.
    Somerfield MR; Einhaus K; Hagerty KL; Brouwers MC; Seidenfeld J; Lyman GH;
    J Clin Oncol; 2008 Aug; 26(24):4022-6. PubMed ID: 18711193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical challenges abound.
    Weber D
    Physician Exec; 2005; 31(2):16-7. PubMed ID: 15844793
    [No Abstract]   [Full Text] [Related]  

  • 13. Central IRBs: why are some institutions reluctant to sign on?
    McNeil C
    J Natl Cancer Inst; 2005 Jul; 97(13):953-5. PubMed ID: 15998943
    [No Abstract]   [Full Text] [Related]  

  • 14. ASCO report highlights challenges in delivering high-quality care.
    Printz C
    Cancer; 2015 Jul; 121(14):2292-3. PubMed ID: 26132387
    [No Abstract]   [Full Text] [Related]  

  • 15. American Society Of Clinical Oncology: revised conflict of interest policy.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jan; 24(3):519-21. PubMed ID: 16365173
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?
    Wieand HS
    J Clin Oncol; 2005 May; 23(15):3643-4; author reply 3646-8. PubMed ID: 15908687
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of independent review to insure ethical quality-improvement activities in oncology: a commentary on the national debate regarding the distinction between quality-improvement initiatives and clinical research.
    Markman M
    Cancer; 2007 Dec; 110(12):2597-600. PubMed ID: 17960605
    [No Abstract]   [Full Text] [Related]  

  • 18. [Off-label use in oncology. The Italian choice].
    Felicetti V; Gremigni U; Cifaldi L
    Recenti Prog Med; 2008 Dec; 99(12):612-5. PubMed ID: 19388222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners.
    Johnston KL; Go RS
    J Natl Cancer Inst; 2007 Sep; 99(18):1415-6. PubMed ID: 17848676
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
    Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
    J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.